Search hospitals > Arkansas > Little Rock
Woodland International Research Group
Claim this profileLittle Rock, Arkansas 72211
Global Leader in Schizophrenia
Global Leader in Depression
Conducts research for Major Depressive Disorder
Conducts research for Bipolar Disorder
Conducts research for Psychosis
104 reported clinical trials
2 medical researchers
Summary
Woodland International Research Group is a medical facility located in Little Rock, Arkansas. This center is recognized for care of Schizophrenia, Depression, Major Depressive Disorder, Bipolar Disorder, Psychosis and other specialties. Woodland International Research Group is involved with conducting 104 clinical trials across 75 conditions. There are 2 research doctors associated with this hospital, such as George Konis, MD and Konis.Top PIs
George Konis, MDWoodland International Research Group1 year of reported clinical research
Studies Schizophrenia
Studies Bunions
11 reported clinical trials
15 drugs studied
KonisWoodland International Research Group1 year of reported clinical research
Studies Postoperative Pain
1 reported clinical trial
1 drug studied
Clinical Trials running at Woodland International Research Group
Schizophrenia
Bunions
Migraine
Anxiety Disorders
Generalized Anxiety Disorder
Sickle Cell Anemia
Sickle Cell Disease
KarXT
for Schizophrenia
This is a Phase 3, 6-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with schizophrenia with an inadequate response to their current atypical antipsychotic treatment. The primary objective of the study is to assess the efficacy of adjunctive KarXT (a fixed dose combination of xanomeline and trospium chloride twice daily [BID]) versus placebo in the treatment of subjects with inadequately controlled symptoms of schizophrenia as measured by the Positive and Negative Syndrome Scale (PANSS) Total Score. The secondary objectives of the study are to evaluate the efficacy of adjunctive KarXT compared with placebo on the Personal and Social Performance Scale (PSP), improvement in disease severity and symptoms, safety and tolerability, and pharmacokinetics.
Recruiting1 award Phase 321 criteria
Iclepertin
for Schizophrenia
This study is evaluating whether a medicine called BI 425809 improves learning and memory in people with schizophrenia.
Recruiting1 award Phase 36 criteria
MK-8189
for Schizophrenia
This study is evaluating whether a drug called MK-8189 may help treat schizophrenia.
Recruiting0 awards Phase 24 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Woodland International Research Group?
Woodland International Research Group is a medical facility located in Little Rock, Arkansas. This center is recognized for care of Schizophrenia, Depression, Major Depressive Disorder, Bipolar Disorder, Psychosis and other specialties. Woodland International Research Group is involved with conducting 104 clinical trials across 75 conditions. There are 2 research doctors associated with this hospital, such as George Konis, MD and Konis.